Tag: pharmaceutical exclusivity
Patent Term Restoration: How Pharmaceutical Companies Legally Extend Market Exclusivity
Posted by Ian SInclair On 30 Jan, 2026 Comments (1)
Patent term restoration lets pharmaceutical companies recover lost patent time due to FDA approval delays. Learn how the Hatch-Waxman Act works, who qualifies, and why it's worth billions.
Generic Drug Patents: How Exclusivity Periods Vary Around the World
Posted by Ian SInclair On 25 Dec, 2025 Comments (8)
Generic drug exclusivity periods vary widely by country, affecting how quickly affordable versions reach patients. The U.S. uses complex patent extensions and market protections, while Europe follows a more predictable 8+2+1 model. These rules shape global drug access and prices.
